Drug Profile
Antibody-drug conjugate companion diagnostics - Leica Biosystems/Byondis
Alternative Names: Research programme: antibody-drug conjugate companion diagnostics - Leica Biosystems/ByondisLatest Information Update: 21 Apr 2020
Price :
$50
*
At a glance
- Originator Leica Biosystems; Synthon
- Developer Leica Biosystems
- Class Antibody diagnostics; Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast cancer; Gastric cancer; Solid tumours
Most Recent Events
- 16 Apr 2020 Synthon Biopharmaceuticals is now called Byondis
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Breast-cancer(Diagnosis) in Belgium
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Breast-cancer(Diagnosis) in Netherlands